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dently formed intranuclear inclusions in the presence ofUbiquitin is a 76-amino acid protein that is covalently
a proteasome inhibitor. After removal of the proteasomelinked to target proteins, and the proteasome recognizes
inhibitor, these inclusions disappeared with chase, sug-and degrades proteins that are tagged with ubiquitin
gesting that inhibition of the proteasome activity corre-chains. The proteasome consists of a cylindrical 20S cata-
lates with the formation of the intranuclear inclusions.lytic particle, capped by PA700 or PA28 regulatory unit.
Taken together, the data suggest that specific mannoseThe ubiquitin/proteasome system plays an important
trimming enhances the efficiency of retrotranslocationrole in the degradation of short-lived and regulatory
of misfolded glycoproteins from the ER lumen to theproteins in a variety of cellular processes, including cell
cytosol, and subsequently they form intranuclear inclu-cycle progression, modulation of cell surface receptors
sions under the inhibition of the proteasome activityand ion channels, and quality control of misfolded pro-
that might be related with the cellular basis of severalteins in the endoplasmic reticulum (ER). Thus, misfolded
neurodegenerative diseases.proteins currently are postulated to be degraded by ubi-
quitin/proteasome pathways after association with ER
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